Trend
DailyDowntrend (confirmed)
4 hourExpanding
1 hourStrong Bearish
15 minStrong Bearish
5 minStrong Bearish
Daily trend turns up above $13.04
Key levels
Resistance$11.61
Resistance$10.80
Support$10.06
Support$9.38
Latest news & SEC filings
SEC FilingNatures Sunshine Products Inc filed an insider trading report (Form 4)
NewsNature's Sunshine Products Files Routine Insider Transaction Reports
All NATR news →Nature's Sunshine is a wellness company that develops and sells dietary supplements and skin and body care items through independent distributors. Its offerings span everyday health, immunity, heart, digestion, beauty, and slimming support. The business runs in four regions: Asia, Europe, North America, and Latin America plus other markets, under the Nature's Sunshine Products and Synergy WorldWide names. Buyers are independent consultants who either use the goods themselves or resell them to end consumers.
Based on the company's 10-K filed Mar 10, 2026.
Nasdaq · Healthcare
SEPT Low Target
$25.00
SEPT Mid Target
$25.00
SEPT High Target
$25.00
Analyst Consensus
$25.00
Thesis
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for NATR.
Start Free Trial →Valuation Verdict
UNDERVALUED
Methods Used
P/E Forward, P/B, Analyst Consensus
Fair Value
$23.02
43
Moat Score
NARROW
6/9
Piotroski Score
4.4
Altman Z-Score
Insider Signal
SELLING
0 buys / 5 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Romanzi Kenneth G. | director officer | Sale | 15,021 | $193K | Nov 4, 2026 |
| Yates Bryant J | officer | Buy | 871 | - | Nov 4, 2026 |
| Yates Bryant J | officer | Sale | 353 | $5K | Nov 4, 2026 |
| Yates Bryant J | officer | Buy | 1,933 | - | Nov 4, 2026 |
| Yates Bryant J | officer | Sale | 783 | $10K | Nov 4, 2026 |
| Norman Daniel C | officer | Buy | 871 | - | Nov 4, 2026 |
| Norman Daniel C | officer | Sale | 353 | $5K | Nov 4, 2026 |
| Norman Daniel C | officer | Buy | 1,933 | - | Nov 4, 2026 |
| Norman Daniel C | officer | Sale | 783 | $10K | Nov 4, 2026 |
| Brower Nathan G | officer | Buy | 717 | - | Nov 4, 2026 |
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →Revenue YoY
5.7%
3yr Revenue CAGR
4.4%
EPS Growth YoY
165%
FCF Growth YoY
101.3%
Revenue Trend
SLOWING
SEPT Investing tracks real-time dark pool institutional trades for NATR, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 20:45:19 | $10.35 | 1,066 | $$11K | MIDPOINT |
| 19:14:45 | $10.39 | 1,052 | $$11K | SELL |
| 16:11:11 | $10.41 | 1,439 | $$15K | BUY |
| 16:06:28 | $10.40 | 1,000 | $$10K | SELL |
| 20:48:50 | $10.96 | 1,000 | $$11K | MIDPOINT |
5 dark pool trades shown · $$58K preview volume
Real-time institutional flow, block trades, and net positioning
SEPT's Trading AI has generated a free, downloadable PDF research report for NATURES SUNSHINE PRODUCTS INC (NATR) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →NATURES SUNSHINE PRODUCTS INC (NATR) is at $10.31, down 5.67% (-$0.62) at the Nov 11, 2026 close.
Latest NATR news — Nov 9, 2026: Natures Sunshine Products Inc filed an insider trading report (Form 4) · Nov 7, 2026: Nature's Sunshine Products Files Routine Insider Transaction Reports
The average analyst price target for NATR is $25.00, ranging from $25 to $25, based on 2 analysts. Latest: Canaccord Genuity maintains on Oct 30, 2026.
Analyst ratings for NATR: 0 Buy, 4 Hold, 0 Sell — consensus Hold.
NATR last reported on Aug 6, 2026: EPS $0.21 vs $0.27 expected — a miss of 22.2%.
NATR trades at a P/E of 12.0 vs a Healthcare average of 17.7.
NATR does not currently pay a dividend.
Support: $10.06, $9.38, $8.26. Resistance: $10.80, $11.61, $12.31.
Insider activity: SELLING, 0 buys and 5 sells in the last 90 days.
Nov 9, 2026: Natures Sunshine Products Inc filed an insider trading report (Form 4) · Nov 7, 2026: Nature's Sunshine Products Files Routine Insider Transaction Reports